Dr Reddy#39;s Labs Q1 Preview: Profit may decline on higher base, but revenue can grow over 5%
Sharekhan sees 167 bps increase in EBITDA margin due to cost savings and better revenue performance.from Moneycontrol Latest News https://ift.tt/2EtPWgK
Sharekhan sees 167 bps increase in EBITDA margin due to cost savings and better revenue performance.
Comments
Post a Comment